Faisal Ahmed, MD
Radiation Oncology · Buena Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 14 years
- University of Utah School of Medicine, 2012
Offices
5 locations · USC Care Medical Group Inc · My MD Inc
Hospitals listed: Foothill Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ahmed’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A137401 · Current
Licensed to practise in California · since 2015 · expires 2027-07-31 · University of Utah School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Radiology - Radiation Oncology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Foothill Regional Medical CenterTustin, CAAcute Care Hospital · Proprietary · No emergency departmentPart of Prospect Medical Holdings, which runs 13 hospitals in 4 statesPatients rate it 1 of 5 · 44% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.087, Oct 2024 – Sep 2025
See every measure and the patient survey for Foothill Regional Medical Center
Behind the star rating — Deaths: 1 better, 2 the same, 0 worse of 3 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 3 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.087 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 256 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.39 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 161 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 919 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,172 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,191 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.08 (0.6 to 5.56) · 205 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 59 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.21 (0.52 to 3.89) · 199 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.13 (0.83 to 9.43) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.25 (0 to 1.09) · 1,850 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 158 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 124 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -98.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 270 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 46 cases | None | Jul 2023 – Jun 2025 |
What patients said (356 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 75% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 60% |
| Doctors "always" listened carefully | 64% |
| Doctors "always" treated them with courtesy and respect | 73% |
| Patients who gave a rating of "9" or "10" (high) | 47% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 44% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 74% |
Original Medicare doctor bills
$19,894
Medicare paid this office $19,894 for 100 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $12,266 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,424 | $143 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,072 | $90 |
| Advance care planning, first 30 minutes | 17 | $1,060 | $62 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of voice box using a flexible endoscope | – | – | 22 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
100 Original Medicare patients in 2024. Average age 75 · Under 65 14% · 85 and older 22% · Women 48% · Also on Medicaid 89% · Health risk score 3.88. Sicker patients than 9 in 10 peers; the typical radiation oncology clinician is at 1.69.
Conditions among them: High blood pressure 75% · Depression 72% · Heart failure 68% · Diabetes 66% · Chronic kidney disease 58% · Dementia 58% · Coronary heart disease 53% · Stroke 48% · COPD 47% · Atrial fibrillation 39% · Cancer 19%.
The office billed $91,184, Medicare allowed $25,102 and paid $19,894; for 196 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 100 | 196 | 75 | 3.88 | $91,184 | $19,894 |
| 2023 | 138 | 245 | 74 | 3.33 | $107,169 | $24,223 |
| 2022 | 66 | 113 | 73 | 3.38 | $50,801 | $10,993 |
| 2021 | 63 | 539 | 73 | 2.59 | $234,709 | $48,029 |
| 2020 | 108 | 1,105 | 73 | 2.03 | $453,085 | $90,411 |
| 2019 | 20 | 149 | 76 | 1.33 | $47,927 | $9,551 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $11,630 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,286 | $143 |
| Critical care, first 30-74 minutes | 14 | $2,895 | $181 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,671 | $99 |
| Advance care planning, first 30 minutes | 22 | $1,492 | $65 |
2022: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $4,383 | $86 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,424 | $89 |
2021: 10 services
| Radiation treatment management, 5 treatment sessions | 28 | $9,871 | $167 |
| Ct guidance for insertion of radiation therapy fields | 22 | $9,064 | $40 |
| High precision radiation therapy planning | 15 | $5,907 | $369 |
| Long return visit (40+ min) | 23 | $5,122 | $125 |
| Design and construction of radiation treatment device for high precision radiation therapy | 14 | $2,970 | $198 |
| New patient visit (60+ min) | 17 | $2,740 | $161 |
| Complex radiation therapy planning | 17 | $2,509 | $148 |
| Design and construction of complex radiation treatment device | 18 | $2,124 | $53 |
| Return visit (30+ min) | 20 | $2,087 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 12 | $1,307 | $59 |
2020: 12 services
| Radiation treatment management, 5 treatment sessions | 44 | $23,394 | $167 |
| Ct guidance for insertion of radiation therapy fields | 51 | $21,394 | $39 |
| High precision radiation therapy planning | 28 | $11,106 | $370 |
| New patient visit (60+ min) | 44 | $6,122 | $139 |
| Design and construction of radiation treatment device for high precision radiation therapy | 28 | $5,966 | $199 |
| Design and construction of complex radiation treatment device | 39 | $4,893 | $53 |
| Complex radiation therapy planning | 24 | $3,505 | $146 |
| 3d radiation therapy planning | 14 | $2,715 | $194 |
| Long return visit (40+ min) | 18 | $2,232 | $97 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 14 | $957 | $18 |
| Calculation of radiation therapy dose | 13 | $804 | $26 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 11 | $494 | $33 |
2019: 1 service
| Ct guidance for insertion of radiation therapy fields | 13 | $4,509 | $39 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 14 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 14 | None | 0% (0) | 0% | $182 |
| 2021 | 133 | 26 | 0% (0) | 14% | $2,825 |
| 2020 | 66 | 26 | 0% (0) | 24% | $1,121 |
| 2019 | 14 | None | 0% (0) | None | $210 |
| 2013 | 121 | 21 | 0% (0) | 26% | $4,476 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 5 drugs
| Gabapentin | 33 | $1,315 | $40 |
| Dexamethasone | 26 | $401 | $15 |
| Fluconazole | 15 | $246 | $16 |
| Silver Sulfadiazine | 13 | $166 | $13 |
| Omeprazole | 17 | $152 | $9 |
2020: 2 drugs
| Gabapentin | 19 | $340 | $18 |
| Ssd | 11 | $279 | $25 |
Money from drug and device companies
$47 in 2025
| 2025 | 1 | 2 | None | $47 |
| 2023 | 3 | 3 | None | $361 |
| 2022 | 1 | 2 | None | $45 |
| 2020 | 2 | 4 | None | $183 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Orgovyx | $47 | 2 payments
|
See all 2 published payments
| Sumitomo Pharma America | Meals · 2025-05-21 | Orgovyx | $26 |
| Sumitomo Pharma America | Meals · 2025-02-14 | Orgovyx | $21 |
See earlier years (2023, 2022, 2020)
2023: $361
| Stryker | Everest Spinal System | $316 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $25 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $20 | 1 payment
|
2022: $45
| Myovant Sciences | Orgovyx | $45 | 2 payments
|
2020: $183
| Novocure | Oncology | $139 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $43 | 2 payments
|
Professional record
- NPI
- 1427314855
- Licence
- CA A137401California A137401: Current · expires 2027-07-31
- Trained
- University of Utah School of Medicine, 2012 · 14 years ago
- Group
- USC Care Medical Group Inc · My MD Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 875 Blake Wilbur Drive, Rm 305, Stanford, CA, 94305
- NPI first listed
- 2012-04-10
- NPI last updated
- 2022-04-21
- NPI record certified
- 2022-04-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 11234 Anderson St, Loma Linda, CA, 92354
This office lists an electronic records connection.